News

Awards, honors, prizes and achievements for the month of November.

A change in the protein composition of chromatin—the condensed, packaged form of DNA in the nucleus—boosts the expression of metastasis-related genes; blocking this change appears to stop tumor cells from forming new tumors in mice, suggests a study by Weill Cornell Medicine investigators. 

A new technology developed by Weill Cornell Medicine and Max Planck Institute for Medical Research scientists allows the controlled, on-and-off “switching” of neural receptors with unprecedented efficiency and precision. 

Weill Cornell Medicine has been awarded a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research to create a center aimed at developing technology to help older adults who have cognitive impairments (CIs).

Dr. Vivian J. Bea, an expert in breast cancer disparities, has been named section chief of breast surgical oncology at NewYork-Presbyterian Brooklyn Methodist Hospital. She also serves as an assistant professor of surgery at Weill Cornell Medicine.

The gene mutation that underlies a puzzling disorder featuring skin, brain and other abnormalities has been discovered by a team of scientists from Weill Cornell Medicine and the Fédération Hospitalo-Universitaire TRANSLAD (FHU-TRANSLAD) in France.

A prestigious Cancer Moonshot grant from the National Cancer Institute’s Immuno-Oncology Translational Network will enable investigators to explore the mechanisms that allow slow-growing lung cancer lesions to progress into aggressive malignancies and identify new therapeutic strategies to intercept the transition. 

Dr. Costantino Iadecola, director of the Feil Family Brain and Mind Research Institute and the Anne Parrish Titzell Professor of Neurology at Weill Cornell Medicine, has been recognized as a 2019 Distinguished Scientist by the American Heart Association for his outstanding contributions to cardiovascular, stroke and dementia research.

A leading drug for tuberculosis (TB) that has begun to lose its potency due to antibiotic resistance can be used to combat the infection through more than one pathway.

Weill Cornell Medicine and GHESKIO have received a two-year $158,000 grant from LINKS to support the institutions’ work addressing high blood pressure in Haiti’s most vulnerable communities.

A book of photos expresses gratitude to Dr. Pak Chung, who for two decades helped parents have their babies.

A high-fat diet increases prostate cancer tumor progression in mice by mimicking the effects of a cancer-promoting gene and may contribute to more aggressive cancer in humans, according to a study from Weill Cornell Medicine and Dana-Farber Cancer Institute investigators.

Drs. Holly Prigerson and Valerie Reyna have combined forces to study end-of-life communication between patients and their physicians and clinicians, with the goal of improved prognostic understanding and decision-making and, ultimately, better end-of-life decisions. They have received a Cornell intercampus seed grant that has sparked additional collaborations and new NIH-funded studies.

The protein adipsin, which is produced in body fat, helps protect insulin-secreting cells called pancreatic beta cells from destruction in type 2 diabetes, according to a new study by researchers at Weill Cornell Medicine and NewYork-Presbyterian. 

Empowering NYC nannies to better care for children—and themselves

In recognition of its outstanding continued commitment to diversity and inclusion, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity (HEED) Award by INSIGHT Into Diversity magazine for the second year in a row.

A protein that breast, lung and other cancers use to promote their spread—or metastasis—to the brain, has been identified by a team led by Weill Cornell Medicine and New York-Presbyterian investigators. The protein, CEMIP, will now be a focus of efforts to predict, prevent and treat brain metastases, which are a frequent cause of cancer deaths.

Awards, honors, prizes and achievements for the month of October.

For patients with a genetic syndrome that predisposes them to many cancers, a new vaccine could be a lifesaver

Personalized medical interventions to improve cardiovascular, metabolic and other modifiable risk factors for Alzheimer’s disease may improve cognitive function, according to a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.